Ci Private Wealth, LLC Esperion Therapeutics, Inc. Transaction History
Ci Private Wealth, LLC
- $59.6 Billion
- Q1 2025
A detailed history of Ci Private Wealth, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 15,000 shares of ESPR stock, worth $28,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 50,745
70.44%
Holding current value
$28,050
Previous $111,000
81.08%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ESPR
# of Institutions
199Shares Held
119MCall Options Held
171KPut Options Held
679K-
Black Rock Inc. New York, NY14MShares$26.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.5MShares$21.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.9MShares$20.4 Million0.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.69MShares$18.1 Million0.32% of portfolio
-
Two Seas Capital LP Rye, NY6.93MShares$13 Million0.36% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $124M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...